Envoy Medical Files 8-K on Financials

Ticker: COCHW · Form: 8-K · Filed: Jul 31, 2025 · CIK: 1840877

Sentiment: neutral

Topics: financial-reporting, sec-filing, operations

TL;DR

Envoy Medical dropped an 8-K on 7/31 detailing financials. Check it out.

AI Summary

Envoy Medical, Inc. filed an 8-K on July 31, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance. Envoy Medical, Inc. is incorporated in Delaware and operates in the orthopedic, prosthetic & surgical appliances & supplies industry.

Why It Matters

This 8-K filing provides investors with crucial updates on Envoy Medical's financial health and operational performance, enabling informed investment decisions.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.

Key Numbers

Key Players & Entities

FAQ

What specific financial information is detailed in the 8-K filing?

The filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details are not provided in this header information.

When was Envoy Medical, Inc. previously known by another name?

Envoy Medical, Inc. was formerly known as Anzu Special Acquisition Corp I, with a date of name change on January 15, 2021.

What is Envoy Medical, Inc.'s primary business sector?

Envoy Medical, Inc. is classified under 'ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES' with SIC code 3842.

Where is Envoy Medical, Inc. headquartered?

The company's business and mailing address is 4875 White Bear Parkway, White Bear Lake, MN 55110.

What is the par value of Envoy Medical, Inc.'s Class Common Stock?

The par value of Envoy Medical, Inc.'s Class Common Stock is $0.0001 per share.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 31, 2025 regarding Envoy Medical, Inc. (COCHW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing